N8 Medical

Focus: N8 Medical is a pre-revenue biotech company focused on developing a novel class of active compounds called ceragenins, headquartered in Dublin, Ohio. The company is currently early-stage with minimal disclosed financial and operational data.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About N8 Medical

AI assessmentNot Hiring

No open roles listed right now. Follow N8 Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CeraShield Endotracheal Tube

Intubation, Intratracheal

N/A

Clinical Trials (1)

NCT03716713CeraShield™ Endotracheal Tube Feasibility Study

N/A

Help build intelligence for N8 Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Novel IP platform: ceragenin technology represents a differentiated mechanism of action with potential first-mover advantage in a nascent therapeutic class
Early-stage opportunity: joining now positions you at the ground floor of a company with significant upside potential if clinical validation succeeds
Specialized niche: rare exposure to a proprietary chemistry platform that is not widely pursued across the industry

Watch Out For

Extreme early-stage risk: only one clinical program (device, not drug), zero published trials, and minimal disclosed funding or financial runway
Zero current hiring: active job count of 0 suggests the company is not actively recruiting or is in a resource-constrained phase
Opaque profile: missing data on founding date, employee count, funding history, and financial metrics makes due diligence difficult

Generated by Claude from N8 Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo